 |
|
|
|
 |
|
|
| Article 1 to 5 out of 5 concerning Solvay Pharmaceuticals
|
-
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals announce receipt of an FDA action letter for bifeprunox
(08/14/2007)
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth, announced the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical ...
-
Morphochem announces determination of the X-ray structure of Endothelin Converting Enzyme (ECE-1) complexed with Phosphoramidon
(12/02/2005)
Morphochem AG has announced that they have successfully achieved an important milestone in their research collaboration with Solvay Pharmaceuticals using Morphochem's structural biology tools to support their Endothelin-Converting Enzyme inhibitor ...
-
Solvay finalizes agreement to buy Fournier Pharma
(07/14/2005)
Solvay announced today that it has signed a final purchase agreement with the shareholders of Fournier Pharma for the acquisition of 100% of the company. Substantial social and regulatory procedures have been successfully completed worldwide. The ...
-
Solvay Pharmaceuticals launches bid to acquire Neopharma in Sweden
(12/21/2004)
SOLVAY PHARMACEUTICALS announces today the launch of a friendly bid to acquire NEOPHARMA, a company based in Uppsala, Sweden. A number of the company's largest shareholders, representing approximately 70% of outstanding shares, have already agreed ...
-
Solvay and Petrovax combine ground breaking skills to produce new flu vaccines in Russia
(11/19/2004)
Solvay Pharmaceuticals cell line to feed Petrovax production unit in Moscow
Solvay Pharmaceuticals and Petrovax Pharm announce the signing of a contract to co-operate on the construction of a facility which will produce new generation flu vaccines near Moscow. Petrovax will own and operate the new factory, which is expected ...
Additional information
Solvay Pharmaceuticals
Marietta, GA, United States of America
Company
|
|
|
|
|
|
Top
